Stocks
Novartis (NVS) ROE US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 35.5% | 35.5% | 11.7% | 11.7% | 31.8% | 38.4% | ||
| Changes by years, y/y, % | +21pp | 0pp | -24pp | 0pp | +20pp | +14.7% | |||
Novartis. ROE, %
Novartis. ROE, changes, pp
Novartis (NVS) ROE US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | 13.5% | 14.8% | 20.5% | 31.8% | 38.4% | 38.4% | |
| Changes by years, y/y, % | -26pp | -22pp | -15pp | +20pp | +25pp | |||
| Changes by quarters, q/q, % | +2pp | +1pp | +6pp | +11pp | +7pp | |||
